Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC2A1 | P11166 | 1/20 | 0.43 |
| ▸ | TLR2 | O60603 | 1/20 | 0.41 |
| ▸ | TLR1 | Q15399 | 1/20 | 0.41 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.39 |
| ▸ | CETP | P11597 | 2/20 | 0.39 |
| ▸ | ROCK2 | O75116 | 1/20 | 0.39 |
| ▸ | ROCK1 | Q13464 | 1/20 | 0.39 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.38 |
| ▸ | SIRT5 | Q9NXA8 | 1/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.38 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.38 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | NPC1 | O15118 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | HPGD | P15428 | 1/20 | 0.38 |
| ▸ | RAB9A | P51151 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL32664938 | 0.90 | MEN1 (0.45) | CETPSLC1A3SLC1A2SLC1A1KDM4E | |
| SCHEMBL32664946 | 0.88 | SLC2A1 (0.47) | SLC2A1MAPK14ROCK2ROCK1KDM4E | |
| SCHEMBL32664976 | 0.82 | RAD52 (0.46) | ROCK2ROCK1ALDH1A1GRIN2BDDR2 | |
| SCHEMBL32664992 | 0.77 | ADH5 (0.42) | MAPK14ROCK2ROCK1KDM4ENPC1 | |
| SCHEMBL32665312 | 0.75 | KDM4E (0.47) | KDM4ENPC1ALDH1A1MAPTHPGD | |
| SCHEMBL32665189 | 0.75 | MAP4K4 (0.45) | CETPL3MBTL1KDM4ENPC1ALDH1A1 | |
| SCHEMBL2267996 | 0.74 | SLC2A1 (0.51) | SLC2A1MAPK14SLC1A3SLC1A2SLC1A1 | |
| SCHEMBL1809969 | 0.73 | RAF1 (0.53) | MAPK14SLC1A3SLC1A2SLC1A1PDK2 | |
| SCHEMBL12991543 | 0.72 | KDM4E (0.54) | SLC1A3SLC1A2SLC1A1KDM4EMAPT | |
| SCHEMBL9798788 | 0.71 | PLAU (0.58) | MAPK14SLC1A3SLC1A2SLC1A1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260022124-A1 | THERAPEUTIC COMPOUNDS AND METHODS | UNIV MINNESOTA (US) | 2026-01-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260022124-A1 | THERAPEUTIC COMPOUNDS AND METHODS | NR5A1, CYP17A1, CNR1 | SLC2A1 2826/4885TLR2 4318/4885TLR1 3290/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.